Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiative
Veit Bücklein(LMU Klinikum), Malte von Bonin(Städtisches Klinikum Dresden), Jan Hoffmann(King's College London), U. Ölschlägel, S. Krause, Michael A. Rieger(Goethe University Frankfurt), Wolfgang Hiddemann(The University of Texas MD Anderson Cancer Center), Cornelia Brendel(Philipps University of Marburg), Thomas Köhnke(California Institute for Regenerative Medicine), Simon Völkl(Universitätsklinikum Erlangen), Marion Subklewe(LMU Klinikum), Frauke Schnorfeil, Tobias Berg(Goethe University Frankfurt)
Unknown
January 1, 2017
Cited by 0
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k